Pierre Fabre, a prominent player in the pharmaceutical and dermo-cosmetics industry, is headquartered in France. Founded in 1962, the company has established itself as a leader in the development of innovative healthcare solutions, particularly in dermatology and oncology. With a strong presence in Europe, North America, and Asia, Pierre Fabre operates across various sectors, including prescription medicines, over-the-counter products, and skincare. The company is renowned for its unique formulations, particularly in its dermo-cosmetic brands such as Avène and Klorane, which are celebrated for their efficacy and skin compatibility. Pierre Fabre's commitment to research and development has led to significant milestones, including numerous patents and collaborations with healthcare professionals. As a trusted name in the industry, Pierre Fabre continues to enhance its market position through a focus on quality and innovation.
How does Pierre Fabre's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Pierre Fabre's score of 31 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Pierre Fabre reported total emissions of approximately 15,100,000 kg CO2e, encompassing Scope 1 and 2 emissions. This figure reflects a slight decrease from 2022, where total emissions were about 16,100,000 kg CO2e. The company has set ambitious targets to reduce its carbon footprint, aiming for a 30% reduction in Scope 1 and 2 emissions by 2025, compared to 2015 levels. This commitment is part of a broader strategy to achieve carbon neutrality across all scopes by 2050. Pierre Fabre's proactive approach to climate action underscores its dedication to sustainability within the cosmetics and pharmaceutical industries, aligning with global efforts to combat climate change. The company continues to monitor and report its emissions, demonstrating transparency and accountability in its environmental initiatives.
Access structured emissions data, company-specific emission factors, and source documents
2021 | 2022 | 2023 | |
---|---|---|---|
Scope 1 | - | - | - |
Scope 2 | - | - | - |
Scope 3 | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pierre Fabre is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.